Drug Target Review – Issue 1 2020

Posted: 23 March 2020 | | No comments yet

This issue includes a spotlight on how genomic assays could revolutionise healthcare, a discussion on how lab automation can improve drug discovery and an analysis of whether antibodies can provide an effective coronavirus treatment. Other article topics in this issue include immuno-oncology and artificial intelligence.

Drug Target Review Issue 1 Front Cover

Included in this issue:

    In vitro platforms for de-risking nephrotoxicity during drug development
    Colin Brown, Newcells Biotech
    Sandy Primrose, Newcells Biotech
    Scientific data management: the core of quality
    Roberto Castelnovo, NL42 Consulting
    Not everyone loves surprises: know your ADC’s critical quality attributes
    Omar Lamm, MilliporeSigma
    Martin De Cecco, Merck
    Cell line development for therapeutic proteins – current perspectives and future opportunities
    Dr Jonathan H Dempsey, Dempsey Consulting
    How labs become AI ready with advanced informatics infrastructures
    Unjulie Bhanot, IDBS

The rest of this content is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here